Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on healthy human subjects - NI

Innovantase research and development services0 个研究点目标入组 24 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•Subjects in age group 18 - 65 years (both the ages inclusive).
•Healthy male & female subjects with skin types as defined in the population details under appendix 1.
•Subjects in good health condition as per the medical screening criteria with no disease state or physical condition that the Investigator believes could interfere with the interpretation of the data.
•Subject able to read, understand and sign an appropriate informed consent form indicating their willingness to participate.
•Subjects willing to maintain the patch test in position for 24 hours.
•Subjects willing to come for regular follow-up visits.
•Subjects ready to follow instructions during the study period.

•Subjects with infection or any skin indications at the test area i.e. back of the subjects.
•Subjects with known history of skin allergy, antecedents or atopic subjects.
•Athletes and subjects with history of excessive sweating.
•Subjects with cutaneous disease which may influence the study result.
•Subjects on oral corticosteroid.
•Subjects participating in any other cosmetic or therapeutic trial.
•Subjects who are pregnant or nursing (self-declared).
•Subjects with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
•Subjects working with MSCR.

发起方

Innovantase research and development services